Stockbridge, MI, United States of America

Lloyd Jerome Simons


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):

Title: The Innovations of Lloyd Jerome Simons: Pioneering Compounds for CNS Disorders

Introduction: Lloyd Jerome Simons is a notable inventor based in Stockbridge, Michigan, recognized for his contribution to the field of pharmaceuticals. His innovative work focuses specifically on the treatment of central nervous system disorders, demonstrating significant potential in this crucial area of healthcare.

Latest Patents: Simons holds a patent for "Substituted morpholine compounds for the treatment of central nervous system disorders." This invention relates to specific compounds designed to alleviate conditions impacting the central nervous system. The patent outlines these compounds' structural formulae, as well as pharmaceutical compositions containing them and their therapeutic applications.

Career Highlights: Lloyd Jerome Simons works for Pfizer Corporation, a leading global pharmaceutical company known for its dedication to research and development in innovative healthcare solutions. His time at Pfizer has allowed him to develop and refine his inventions that aim to enhance treatment options for neurological conditions.

Collaborations: Throughout his career, Simons has collaborated with a talented team, including colleagues Nancy Sue Barta and Shelly Ann Glase. Together, they have combined their expertise to drive forward research and development in the pharmaceutical sector, creating valuable medical advancements.

Conclusion: Lloyd Jerome Simons has made a meaningful impact in the realm of pharmaceutical innovations, specifically concerning the treatment of central nervous system disorders. Through his patent and collaborative efforts at Pfizer Corporation, he continues to contribute to the advancement of medical science and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…